HopeStage
Back to all studies
WithdrawnNCT01758887

Antipsychotic Discontinuation in High-risk Subjects

Observational studyAges 16–40South KoreaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 40 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2012
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Seoul National University Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
South Korea
Age range
From 16 Years to 40 Years
Official registry ID
NCT01758887
Official title
Show the full official title

Antipsychotic Discontinuation in High-risk Subjects

Recruitment & locations

Withdrawn

Seoul

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Seoul National University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 16 years to 40 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies